Tekla Capital Management

Tekla Capital Management

Tekla Capital Management

Suggest edits
Follow us
Also headquartered in Boston
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 11

Portfolio

Portfolio Tracker

Add info
Northstack

Oculis raises $57m Series C led by BVCF Management and Hyfinity Investments

Oculis
Oculis
€30,000,000 Venture capital (Series A)
FinSMEs

Priothera Raises €30M in Series A Financing

Priothera
Priothera
SiliconRepublic

Dublin’s Priothera raises €30m to develop leukaemia treatment

Priothera
Priothera
$65,000,000 Venture capital (Series B)
FinSMEs

HotSpot Therapeutics Closes $65M Series B Financing

HotSpot Therapeutics
HotSpot Therapeutics
Xconomy

HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic

HotSpot Therapeutics
HotSpot Therapeutics
$55,000,000 Venture capital (Series C)
Xconomy

Dynacure Adds $55M As RNA-Targeted Muscle Disorder Drug Enters Clinic

Dynacure
Dynacure
Xconomy

With “Inflection Year” Ahead, Ovid Adds Novartis’s Tardio to C-Suite

Ovid Therapeutics
Ovid Therapeutics
Novartis
Novartis
$113,800,000 IPO
PE HUB

Biopharma firm Atreca goes public

Atreca, Inc.
Atreca, Inc.
FinSMEs

Pfizer Acquires Clinical-Stage Biotech Company Therachon, for Up To $810M

Pfizer
Pfizer
Therachon
Therachon
Silicon Canals

Swiss startup Oculis secures €13.8M funding to treat ophthalmic diseases

Oculis
Oculis
$15,711,870 Venture capital (Series B)
FinSMEs , PE HUB

Oculis Raises CHF15.5M in Extension of Series B Financing

Oculis
Oculis
$80,000,000 Venture capital
FinSMEs

Milestone Pharmaceuticals Raises $80M in Equity Funding

Funding Health
Milestone Pharmaceuticals, Inc.
Milestone Pharmaceuticals, Inc.
$125,000,000 Venture capital (Series C)
FinSMEs , PE HUB , MedCity News

Atreca Raises $125M in Series C Funding

Funding
Atreca, Inc.
Atreca, Inc.
$60,000,000 Venture capital (Series B)
FinSMEs

Biotech Company Therachon Raises $60M Mezzanine Financing

Funding Health
Therachon AG
Therachon AG
Therachon
Therachon
$45,000,000 Venture capital (Series A)
PE HUB , FinSMEs

HotSpot Therapeutics scores $45 mln Series A

Data leaks Messaging
HotSpot Therapeutics
HotSpot Therapeutics
$20,000,000 Venture capital (Series B)
FinSMEs

BioClin Therapeutics Raises $20M; Completes $50M Series B Financing

Funding Health
BioClin Therapeutics
BioClin Therapeutics
PE HUB

| Oculis nabs $20.3 mln Series B

Funding Health
Oculis
Oculis
$20,300,000 Venture capital (Series B)
Norðurskautið , FinSMEs

Oculis raises $20.3m Series B round to advance treatment for Ophthalmic Diseases

Funding Health
Oculis
Oculis
$35,000,000 Venture capital (Series B)
PE HUB , PE HUB

Atreca raises $35 mln Series B co-led by Wellington

Funding
Atreca, Inc.
Atreca, Inc.
$75,000,000 IPO
Xconomy

With $75M Haul, Ovid Continues Flurry of Biotech IPOs

Health Science